{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T14:34:17Z","timestamp":1767364457655,"version":"3.48.0"},"reference-count":20,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,9,18]]},"published-print":{"date-parts":[[2026,1]]},"DOI":"10.2967\/jnumed.125.270239","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T15:15:11Z","timestamp":1761837311000},"page":"92-95","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Impact of Changes in Tumor Uptake and Volume on PSMA PET\/CT During [\n                    <sup>177<\/sup>\n                    Lu]Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer"],"prefix":"10.2967","volume":"67","author":[{"given":"Lo\u00efc","family":"Djaileb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Farolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Rauscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahan","family":"Haghighatian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang P.","family":"Fendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Hadaschik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilja B.","family":"Solnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Rettig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Czernin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremie","family":"Calais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias R.","family":"Benz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Gafita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"2026010206300899000_67.1.92.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"2026010206300899000_67.1.92.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057307"},{"key":"2026010206300899000_67.1.92.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05970-y"},{"key":"2026010206300899000_67.1.92.4","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1007\/s00259-022-05882-x","article-title":"Measuring response in metastatic castration-resistant prostate cancer using PSMA PET\/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria","volume":"49","author":"Gafita","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300899000_67.1.92.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263072"},{"key":"2026010206300899000_67.1.92.6","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.7150\/thno.96738","article-title":"PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: is there value beyond localization of disease?","volume":"14","author":"K\u00fcper","year":"2024","journal-title":"Theranostics."},{"key":"2026010206300899000_67.1.92.7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00259-018-4236-4","article-title":"Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer","volume":"46","author":"Grubm\u00fcller","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300899000_67.1.92.8","doi-asserted-by":"crossref","first-page":"578093","DOI":"10.3389\/fonc.2021.578093","article-title":"In comparison to PSA, interim Ga-68-PSMA PET\/CT response evaluation based on modified RECIST 1.1 after 2nd cycle is better predictor of overall survival of prostate cancer patients treated with 177Lu-PSMA","volume":"11","author":"Prasad","year":"2021","journal-title":"Front Oncol."},{"key":"2026010206300899000_67.1.92.9","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.7150\/thno.60222","article-title":"Total tumor volume reduction and low PSMA expression in patients receiving Lu-PSMA therapy","volume":"11","author":"Seifert","year":"2021","journal-title":"Theranostics."},{"key":"2026010206300899000_67.1.92.10","doi-asserted-by":"crossref","first-page":"1538507","DOI":"10.3389\/fmed.2025.1538507","article-title":"Study of predictive factors for response to 177Lu-PSMA in patients with metastatic castration-resistant prostate cancer","volume":"12","author":"Peslier","year":"2025","journal-title":"Front Med (Lausanne)."},{"key":"2026010206300899000_67.1.92.11","unstructured":"S3 guideline prostate cancer (version 8.1). Leitlinienprogramm Onkologie website. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/prostatakarzinom. Accessed October 14, 2025."},{"key":"2026010206300899000_67.1.92.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30198-0"},{"key":"2026010206300899000_67.1.92.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261982"},{"key":"2026010206300899000_67.1.92.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.171397"},{"key":"2026010206300899000_67.1.92.15","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-014-0063-1"},{"key":"2026010206300899000_67.1.92.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04485-3"},{"key":"2026010206300899000_67.1.92.17","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026010206300899000_67.1.92.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.224055"},{"key":"2026010206300899000_67.1.92.19","doi-asserted-by":"crossref","first-page":"S970","DOI":"10.1016\/j.annonc.2024.08.1689","article-title":"1608P Prostate Cancer Working Group 4 (PCWG4) preliminary criteria using serial PSMA PET\/CT for response evaluation: analysis from the PRINCE trial [abstract]","volume":"35","author":"Hofman","year":"2024","journal-title":"Ann Oncol."},{"key":"2026010206300899000_67.1.92.20","doi-asserted-by":"crossref","first-page":"e222148","DOI":"10.1148\/radiol.222148","article-title":"Response evaluation criteria in PSMA PET\/CT (RECIP 1.0) in metastatic castration-resistant prostate cancer","volume":"308","author":"Gafita","year":"2023","journal-title":"Radiology."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.270239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T14:30:21Z","timestamp":1767364221000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.270239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,2]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.2967\/jnumed.125.270239"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.270239","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"type":"print","value":"0161-5505"},{"type":"electronic","value":"2159-662X"}],"subject":[],"published":{"date-parts":[[2025,10,30]]}}}